Back to search
FDAFDA · Food and drugs·Recall number Z-2425-2024

RX Series CYSC- Cystatin C Reagent -Intended for in vitro diagnostic (IVD) use as Randox Cystatin C assay on automated analysers. Catalogue Number: CYS4004

Published July 31, 2024 · Recall initiated: June 7, 2024

Summary

FDA records medical device Class II recall Z-2425-2024, published July 31, 2024 and initiated June 7, 2024. Recalling firm: Randox Laboratories Ltd.; Status: Ongoing; Reported quantity: 115 kits; Lot: GTIN: 05055273208665 All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cystatin C Reagent marketed without a 510 (k)

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Randox Laboratories Ltd.
Distributor
US Nationwide distribution in the states of AL, CA, GA, NY.
Lot
GTIN: 05055273208665 All lots
Risk classification
Class II
Area (FDA)
device
Country
Ireland

Related recalls

Questions about this recall

Was RX Series CYSC- Cystatin C Reagent -Intended for in vitro diagnostic (IVD) use as Randox Cystatin C assay on automated analysers. Catalogue Number: CYS4004 recalled?

Yes. FDA published recall Z-2425-2024 on July 31, 2024. Reported hazard: Cystatin C Reagent marketed without a 510 (k)

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail